Leoš Pleva

Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis

Daniele Giacoppo, Fernándo Alfonso, Bo Xu et al. · Journal of the American College of Cardiology · 2020 · 196 citations · Full text

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Johanne Silvain, Benoît Lattuca, Farzin Beygui et al. · The Lancet · 2020 · 122 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +10

Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis

Leoš Pleva, Pavel Kukla, Pavlína Kušnierová et al. · Circulation Cardiovascular Interventions · 2016 · 87 citations

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Muthiah Vaduganathan, Robert A. Harrington, Gregg W. Stone et al. · Journal of the American College of Cardiology · 2017 · 56 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +8

Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency

Leoš Pleva, Pavlína Kušnierová, Pavlína Plevová et al. · Biomedical Papers · 2015 · 19 citations · Full text